این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Archives of Anesthesiology and Critical Care، جلد ۱، شماره ۴، صفحات ۱۱۶-۱۱۹
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Evaluation of Ventilator-Associated Pneumonia According to Stress Related Mucosal Disease Prophylaxis Regimen in the Intensive Care Unit
چکیده انگلیسی مقاله Background: Ventilator-associated pneumonia (VAP) increases the cost of intensive care unit (ICU) treatment and the chance of mortality. Due to the increasing use of proton pump inhibitors (PPI) and H2 receptor inhibitors for stress ulcer prophylaxis, the purpose of the study was to investigate the differences of VAP in two groups of patients receiving PPI or H2 blocker. Methods: In the retrospective cross sectional study, from September 2011 to September 2012, 43 patients who had positive pulmonary cultures (PC) were studied. These patients had a clinical pulmonary infection score (CPIS) ≥6 for more than 48 hours after receiving stress related mucosal diseases prophylaxis (SRMD). Patients whose SRMD prophylaxis was changed within 72 hours before obtaining the PC samples were excluded. Patients were divided into two groups. One group received pantoprazole (20 cases) and the other group received ranitidine (23 cases). Between the groups, age, sex, APACHE II score, predicted mortality, type of used SRMD prophylaxis drug, duration of prophylaxis prior to PC sampling, interval time between ICU admission and VAP manifestation, the type of bacterial causes of VAP, gastrointestinal bleeding, ICU length of stay and actual mortality were compared. Results: The APACHE II score and predicted mortality were higher in the pantoprazole group (P=0.173, 0.167). We found that 30% of the ranitidine group suffered from upper GI bleeding. In the pantoprazole group, 21.74% suffered from upper GI bleeding (P< 0.001). Patients receiving ranitidine had a higher mortality rate and a worse prognosis (P< 0.001). Conclusion: Although there were more critically ill patients with a higher predicted mortality in the pantoprazole group, the ranitidine recipients turned out to have a higher mortality rate.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله محمد رضا حاجی اسماعیلی | mohammad reza hajiesmaeili
beheshti university of medical science


امید مرادی مقدم | omid moradi moghadam
iran university of medical science


علیرضا صداقت | alireza sedaghat
mashhad university of medical science


محمد نیاکان | mohammad niakan
iran university of medical science


شهرام سیفی | shahram seifi
babol university of medical science


فرشید رحیمی بشر | farshid rahimi bashar
hamadan university of medical science


امیر واحدیان عظیمی | amir vahedian azimi
baqiyatallah university of medical sciences

سازمان اصلی تایید شده: دانشگاه علوم پزشکی بقیه الله (Baqiyatallah university of medical sciences)

حسنا forooghirad | hosna forooghirad
shahid beheshti university of medical science

سازمان اصلی تایید شده: دانشگاه شهید بهشتی (Shahid beheshti university)

داود یادگاری نیا | davood yadegarynia
shahid beheshti university of medical science

سازمان اصلی تایید شده: دانشگاه شهید بهشتی (Shahid beheshti university)

دکتر محمد فتحی | mohammad fathi
shahid beheshti university of medical science

سازمان اصلی تایید شده: دانشگاه شهید بهشتی (Shahid beheshti university)

نشانی اینترنتی http://aacc.tums.ac.ir/index.php/aacc/article/view/38
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Research Article(s)
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات